Today, and this week will allow us to know in which direction this is heading (SHORT-TERM).
~Earnings Call 3/29/2018 ~
If the (A)ctual-EPS is disturbing we might get an interesting trend that could take a few months to recover to CURRENT price levels. Nobody wants to wait long periods of time for them to possibly break-even.
I do like the expansion in CHINA markets. That's a very bullish sign for me, and also for the overall direction of the company. It's a fairly small company with 26 FULL-TIME employees, which for a BIOTECHNOLOGY company that's quite small. But the execution they're achieving is great for such a team!
Executive Comp: Also on the lower side by at least 2/3 of average BIOTECH companies. Good sign the company isn't bloating EXEC COMP. :)
Now back to the meat & potatoes;
Short-term CASI isn't looking good because,
If short-term performs well, I'm liking this over $4.15 EASY. Could reach some 52-Week HIGHS & if 2018 performs well Q1 & Q2, expect this to break that 52 week ATH of $4.84 like a High school boys Heart on Valentine's Day.
Watch what CASI does around 200EMA first. Will be easy money after we know the trend.
Take this with a grain of salt.
Happy Trading!
~Earnings Call 3/29/2018 ~
If the (A)ctual-EPS is disturbing we might get an interesting trend that could take a few months to recover to CURRENT price levels. Nobody wants to wait long periods of time for them to possibly break-even.
I do like the expansion in CHINA markets. That's a very bullish sign for me, and also for the overall direction of the company. It's a fairly small company with 26 FULL-TIME employees, which for a BIOTECHNOLOGY company that's quite small. But the execution they're achieving is great for such a team!
Executive Comp: Also on the lower side by at least 2/3 of average BIOTECH companies. Good sign the company isn't bloating EXEC COMP. :)
Now back to the meat & potatoes;
Short-term CASI isn't looking good because,
- Short-Term Moving Average has been crossed towards the downside.
- Long-Term MACD has officially also crossed from peak levels.
- Short-Term MACD has barely reached 0.00 and could go towards negative levels.
- The overall market is in a downturn which is effecting many companies in general.
- The BIOTECH industry is currently down 3% last 5-Days & 8% last 14-Days.
If short-term performs well, I'm liking this over $4.15 EASY. Could reach some 52-Week HIGHS & if 2018 performs well Q1 & Q2, expect this to break that 52 week ATH of $4.84 like a High school boys Heart on Valentine's Day.
Watch what CASI does around 200EMA first. Will be easy money after we know the trend.
Take this with a grain of salt.
Happy Trading!
Glad it didn't drop towards the 200EMA but instead busted towards the upside by a magnificent percentage change!
Hope you all sold shares at 4%, 7%, and 10%. Have to manage risk tightly as my job is to control capital and increase its value.
Now the uptrend is moving beautifully up, but tomorrow 3/30/2018 could be a pullback day from todays impeccable performance. I'll look into this tonight and update on further action.
Happy Trading!